A Phase 2, Single-Center, Open-Label, Pharmacodynamic Clinical Trial to Evaluate the Effect of Technosphere Insulin Inhalation Powder on Postprandial Glucose Levels in Subjects With Type 1 and Type 2 Diabetes Mellitus Ingesting Meals With Varied Carbohydrate Content.

Trial Profile

A Phase 2, Single-Center, Open-Label, Pharmacodynamic Clinical Trial to Evaluate the Effect of Technosphere Insulin Inhalation Powder on Postprandial Glucose Levels in Subjects With Type 1 and Type 2 Diabetes Mellitus Ingesting Meals With Varied Carbohydrate Content.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 28 Oct 2014

At a glance

  • Drugs Insulin lispro (Primary) ; Insulin
  • Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors MannKind Corporation
  • Most Recent Events

    • 20 Oct 2014 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
    • 13 Jul 2011 Actual end date changed from Feb 2011 to May 2011 as reported by ClinicalTrials.gov.
    • 10 Mar 2011 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top